Literature DB >> 2996402

Antigens of human T-lymphotropic virus type III/lymphadenopathy-associated virus.

M Essex, J Allan, P Kanki, M F McLane, G Malone, L Kitchen, T H Lee.   

Abstract

Antigens encoded by the gag and env genes of the human T-lymphotropic virus type III/lymphadenopathy associated virus (HTLV-III/LAV) include a p55 gag polyprotein that yields p24 as the major virus core protein, and an env gene polyprotein, gp 160, that produces gp 120, the most immunogenic protein in humans, at the amino terminus. Although its use is limited to research laboratories due to the cost and specialized procedures involved, the analysis of sera by radioimmunoprecipitation and sodium dodecyl sulfate-polyacrylamide gel electrophoresis is the test providing the optimal balance of specificity and sensitivity. Because the gp 120 represents the external virus protein, it would be the most appropriate antigen for vaccine development. Also viruses serologically related to HTLV-III/LAV were detected recently in two species of Old World monkeys. Because about half the healthy African green monkeys appear to have been exposed to simian T-lymphotropic virus type III (STLV-III), a related agent of the species, a characterization of the STLV-III gp 120 and immune response of the host may provide additional information for vaccine development.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Antibodies; Antigen-antibody Reactions; Biology; Clinical Research; Diseases; Examinations And Diagnoses; Hematologic Tests; Hiv Infections; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Laboratory Procedures; Physiology; Proteins; Research Methodology; Viral Diseases

Mesh:

Substances:

Year:  1985        PMID: 2996402     DOI: 10.7326/0003-4819-103-5-700

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  11 in total

1.  Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.

Authors:  J M Lange; D A Paul; H G Huisman; F de Wolf; H van den Berg; R A Coutinho; S A Danner; J van der Noordaa; J Goudsmit
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

2.  Measurement of antibodies to human immunodeficiency virus: an international collaborative study to evaluate WHO reference sera.

Authors:  A J Garrett; V Seagroatt; E M Supran; K O Habermehl; H Hampl; G C Schild
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

Review 3.  Practical diagnostic testing for human immunodeficiency virus.

Authors:  J B Jackson; H H Balfour
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

4.  A Critical Look at HIV-Antibody Tests: 1. How Accurate Are They?

Authors:  J W Frank; V Goel; B J Harvey; R A Coates; V Schiralli
Journal:  Can Fam Physician       Date:  1987-09       Impact factor: 3.275

5.  Cell surface expression of several species of human immunodeficiency virus type 1 major core protein.

Authors:  A G Laurent; B Krust; M A Rey; L Montagnier; A G Hovanessian
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Oral manifestations of human immunodeficiency virus infection.

Authors:  J B Epstein; R G Mathias
Journal:  Can Fam Physician       Date:  1988-08       Impact factor: 3.275

7.  Variations in Western blot banding patterns of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus.

Authors:  D S Burke; R R Redfield; P Putman; S S Alexander
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

Review 8.  Vaccine and antiviral strategies against infections caused by human immunodeficiency virus.

Authors:  M A Wainberg; O Kendall; N Gilmore
Journal:  CMAJ       Date:  1988-05-01       Impact factor: 8.262

9.  Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.

Authors:  T J Matthews; A J Langlois; W G Robey; N T Chang; R C Gallo; P J Fischinger; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

10.  Immunogenicity of human immunodeficiency virus (HIV) reverse transcriptase: detection of high levels of antibodies to HIV reverse transcriptase in sera of homosexual men.

Authors:  R Chatterjee; C R Rinaldo; P Gupta
Journal:  J Clin Immunol       Date:  1987-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.